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Temporal Development of Gut
Microbiota in Triclocarban Exposed
Pregnant and Neonatal Rats
Rebekah C. Kennedy1,2,*, Russell R. Fling3,*, Michael S. Robeson4,5, Arnold M. Saxton6,
Robert L. Donnell7, John L. Darcy8, David A. Bemis7, Jiang Liu3, Ling Zhao9 & Jiangang Chen1
Alteration of gut microbial colonization process may influence susceptibility of the newborn/infant
to infectious and chronic disease. Infectious disease risk leads to widespread use of non-prescription
antimicrobials in household products such as Triclocarban (TCC), an antimicrobial compound in
personal care products. TCC concentrates in and is transferred through the milk to suckling offspring.
TCC exposure during gestation and lactation significantly reduced phylogenetic diversity (PD)
among exposed dams and neonates. Among dams using weighted UniFrac distances, TCC induced
significant dysbiosis of gut microbiota by gestational day (GD) 18, a trend that continued after delivery.
Similarly, an overall restructuring of gut microbiota occurred in neonates. By postnatal day (PND) 12,
communities separated based on exposure status and became significantly different at PND 16. The
ability of TCC to drive microbial dysbiosis warrants future investigation to evaluate the safety of nonprescription antimicrobial use, including TCC, during critical exposure windows.
Though it has commonly been estimated that bacteria cells outnumber human cells 10 to 1, more recent estimates
suggest that a 1 to 1 ratio may be a more appropriate calculation1. The collective gut microbiota can act as an
“ancillary organ” with a critical function in human health including regulation of host metabolism and energy
balance, immune function stimulation, maintenance of host nutritional physiological homeostasis, and defense
against pathogens2,3. Indigenous gut microorganisms occupy available intestinal niches, therefore any transient
species derived from the environment will not colonize and will instead pass through the gastrointestinal system4.
In contrast, alteration or imbalance of the composition of commensal bacterial population could induce transient
or permanent damage to the host with profound health consequences5.
At birth, microbial colonization is largely a product of the host environment and is tied to a variety of factors
including delivery (vaginal/caeseran) and infant feeding mode (breast/formula feeding)6,7. The evolvement of
infant gut microbial composition is dynamic with large community shifts that occur at transitional stages, i.e.
when solid foods are introduced or during early exposure to prescription antibiotics8,9. Close to the conclusion
of the first year, the infant acquires a less dynamic gut microbial community that gradually converges to a more
adult-like profile8.
The composition of the gut microflora can have a broad impact on the health of the host; it is well established
that prescription antibiotic exposure can disrupt the balance of the intestinal microbiota potentially leading to
unintentional side-effects; alteration of the colonization process may influence susceptibility of newborn/infant
to infectious disease in the short-term and lead to immune mediated and metabolic disorders later in life3,5. More
than 40% of pregnant women are prophylactically prescribed antibiotics during pregnancy/birth for prevention of preterm labor, intrapartum fever, vertical pathogen transmission to the infant, and maternal morbidity
after caesarean section10. While the average pregnant or lactating female does not control the use of prescription
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Figure 1. Alpha diversity of dams during gestation and lactation. Shannon’s diversity index (A) and
phylogenetic diversity (B) is shown at Gestational day (GD) 4 (baseline), 11, 18 and 16 days after delivery (AD)
(control: gray bar, 0.1% w/w TCC: black bar; n = 4/group). Data represent mean ± SEM of each group. Data
were analyzed with two-way ANOVA with repeated measures followed by Bonferroni post-hoc test. Statistical
significance was set at p = 0.05; (*) indicates statistical significance at each time point relative to controls.

antibiotics, precaution and fear of infectious disease outbreak in human populations leads to widespread use of
non-prescription antimicrobials in household products11,12. It is estimated that more than 10 million women are
either pregnant or lactating in the United States at any given time and the use of antimicrobial personal care products occurs among this population without confidence in the safety of antimicrobial exposure during early-life
periods11–13. Specifically, the impact of early-life non-prescription antimicrobial compound exposure on both
intestinal microbiota community integrity and the resultant health outcomes are understudied.
Triclocarban (3,4,4′-trichlorocarbanilide; TCC) is a high production volume antimicrobial, used in personal
care products, at a mass of up to 1.5% in certain brands of bar soaps11,14. TCC can be absorbed through the
skin and has been detected in adult human urine, serum and in cord blood indicating exposure throughout the
lifespan15–17. Volunteers with frequent exposure through the application of TCC containing products tend to have
a higher TCC body burden in the circulation18. Recent evidence demonstrates that human exposure to TCC may
not be limited to the purposeful use of antimicrobial products, but could occur through the diet19. Following
incomplete removal by wastewater treatment process, TCC is detected in nutrient-rich sludge that may be applied
as agricultural fertilizer leading to safety concerns regarding the potential intake through the food chain20.
Previously our group reported that TCC concentrates in the breast milk after dietary exposure in a rodent
model indicating potential neonatal TCC exposure via lactation21. Furthermore, neonates with TCC exposure
during lactation had distended gastrointestinal tracts with liquid, mustard-colored diarrhea implying the disturbance of intestinal microbiota and hence a dysbiotic status. In this report, we utilized a rodent model to investigate and characterize the temporal dynamics of intestinal microbiota in pregnant dams and neonatal rats in
response to TCC exposure during gestation and lactation.

Results

Influence of Gestational and Lactational TCC Exposure on Dam Fecal Microbiota. Alpha and
Beta Diversity. After quality filtering and removal of any OTU present at less than 0.005% of the total read
count, 54 samples comprised of 4,931,803 sequences remained with an average of 91,330 sequences per sample.
Neither Shannon’s index nor phylogenetic diversity differed between control and exposed dams prior to TCC
exposure at baseline (GD 4). TCC exposure significantly reduced the diversity of microbiota in feces of treated
animals compared to controls at 7 days after treatment (GD 11: Shannon 4.93 ± 0.088 vs 3.73 ±  0.180, Fig. 1A;
PD 26.5 ± 0.338 vs 21.7 ± 0.277, Fig. 1B). This trend continued throughout gestation after 14 days of treatment at
GD 18 (Shannon 4.97 ± 0.077 vs 3.50 ± 0.123, Fig. 1A; PD 25.9 ± 0.204 vs 19.1 ± 0.522, Fig. 1B) and into lactation
16 days after delivery (AD 16), corresponding to 34 days of TCC exposure when both measures were significantly suppressed in the exposed dams compared to controls (Shannon 4.59 ± 0.109 vs 4.14 ± 0.051, Fig. 1A; PD
25.9 ± 0.143 vs 19.4 ± 0.272, Fig. 1B; two-way ANOVA, p <  0.05).
Increasing microbial community dissimilarity of TCC exposed vs control dams was pronounced at GD11
and maintained over time (Fig. 2, Supplementary Fig. S1). Microbiota structure became statistically dissimilar
by 14 days of treatment (GD 18; R2 = 0.69, Adonis p < 0.05) and remained different until AD 16 (34 days of TCC
exposure; R2 = 0.69, Adonis p < 0.05). Repeated measures analysis revealed a significant interaction between time
and treatment (R2 = 0.27, Adonis p < 0.05). Post-hoc analysis demonstrated that a significant time-treatment
interaction occurred beginning at GD 11 after which microbial communities in control and treatment dams
behaved differently.
Fecal Microbiota Community Composition. Figure 3 shows the relative abundance of the gut microbial community composition of dams over time, during pregnancy and lactation. Visually, the effect of TCC was more
pronounced at the family than the phylum level (Fig. 3A,B). Across the study period in control dams, S24-7
dominated fecal microbiota. While the Bacteroideaceae family was overrepresented in the microbiota of dams
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Figure 2. Beta diversity of dams during gestation and lactation. Pairwise weighted UniFrac distance between
TCC exposed and control dams is shown among dams at Gestational Days (GD) 4 (baseline), 11, 18 and 16 days
after delivery (AD); n = 4/group. Statistical significance of community level microbial distance was analyzed
with Adonis, in the Vegan package, at each collection date50,51. Repeated measures analysis was conducted
and significant time-treatment interactions were investigated with the Vegan package. (*) indicates statistical
significance at each time point relative to controls.

Figure 3. Relative abundance of bacteria among dams at the phylum (A) and family (B) levels by collection
date at GDs 4 (baseline), 11, 18 and 16 days after delivery (AD) (n = 4/group). At the family level, only the top
100 OTUs are shown. Taxon labeled within square brackets indicate GreenGenes proposed taxonomy.

exposed to 0.1% w/w TCC. Significant differences at the phylum and family level across time and exposure groups
are shown in Tables 1 and 2 respectively.
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Least Squares Means**

Phylum*

Stain

BacteroidetesC

Gram −
Gram +

FirmicutesC
Proteobacteria

ABC

Gram −
Gram −

TenericutesAB

Group

GD 4 GD 11 GD 18 AD 16

Control

42.6

24.6

30.7

46.4

Exposed

41.1

39.3

65.2

20.6

Control

48.0

71.9

65.5

48.7

Exposed

56.0

56.4

30.1

69.5

Control

2.7

<1

2.0

2.1

Exposed

1.3

4.1

4.3

9.3

Control

2.5

1.4

<1

1.7

Exposed

1.1

<1

<1

<1

Table 1. Effect of TCC on Relative Abundance of Dam Gut Microbial Phyla. A = Effect of time, p <  0.05;
B = Effect of treatment, p <  0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1%
of the relative abundance. **Least squares means displayed as percentage; GD = gestational day; AD =  after
delivery.

Least Squares Means**

Family*

Stain

[Paraprevotellaceae]ABC

Gram −
Gram −

AlcaligenaceaeC
Bacteroidaceae

Gram −

ClostridiaceaeB

Gram +

DesulfovibrionaceaeABC

Gram −

ABC

EnterobacteriaceaeABC

Gram −
Gram +

LactobacillaceaeB
Porphyromonadaceae

ABC

Rikenellaceae

BC

RuminococcaceaeAC
S24−7ABC
TuricibacteraceaeAB

Gram −
Gram −
Gram +
Uncultured
Gram +

Group

GD4

GD 11

GD 18

AD 16

Control

<1

<1

<1

<1

Exposed

<1

1.5

4.5

<1

Control

2.1

<1

1.3

<1

Exposed

<1

2.7

2.0

<1

Control

2.5

3.8

7.7

7.3

Exposed

1.1

34.8

56.1

18.9

Control

2.0

3.8

3.4

2.4

Exposed

1.2

<1

<1

<1
<1

Control

<1

<1

<1

Exposed

<1

<1

2.0

2.5

Control

<1

<1

<1

<1

Exposed

<1

<1

<1

6.0

Control

1.5

3.2

1.6

4.4

Exposed

2.2

<1

<1

1.7

Control

1.5

<1

<1

<1

Exposed

<1

2.8

4.2

1.3

Control

<1

2.8

1.9

4.3

Exposed

<1

<1

<1

<1

Control

18.9

17.8

19.6

15.8

Exposed

16.8

33.8

10.1

21.4

Control

37.4

14.9

18.5

32.5

Exposed

38.5

<1

<1

<1

Control

1.1

1.0

1.1

<1

Exposed

1.1

<1

<1

<1

Table 2. Effect of TCC on Relative Abundance of Dam Gut Microbial Families. A = Effect of time, p <  0.05;
B = Effect of treatment, p <  0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1%
of the relative abundance; **Least squares means displayed as percentage; GD = gestational day; AD =  after
delivery.

Influence of Gestational and Lactational TCC Exposure on Neonatal Microbiota. Alpha and Beta
Diversity. Among neonates, Shannon’s index did not differ between the two groups across the study period
Fig. 4A. Phylogenetic diversity became significantly different on PND 16 (PD 19.51 ± 0.59 vs 9.18 ±  1.35 Fig. 4B;
ANCOVA, p < 0.05). The effect of TCC exposure on beta diversity is shown in Fig. 5 and Supplementary Fig. S2
using weighted UniFrac distances. Regardless of treatment status, an initial stochastic pattern emerged at PND 3
followed by convergence at PND 6. After PND 6, the weighted UniFrac distances behaved similarly between control and exposed groups. By PND 12, separation based on treatment status occurred which became significantly
different at PND 16 (R2 = 0.87, Adonis p < 0.05). Repeated measures analysis revealed an effect of collection date
(R2 =  0.25).
Given the pattern of diversity shown in Fig. 5 and Supplementary Fig. S2, where a variable configuration
arises at PND 3, followed by reorganization and subsequent separation based on exposure status coupled with
Scientific Reports | 6:33430 | DOI: 10.1038/srep33430
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Figure 4. Alpha diversity of neonates during lactation period. Shannon’s diversity index (A) and phylogenetic
diversity (B) is shown at postnatal days (PND) 3, 6, 12 and 16 (control: gray bar, 0.1% w/w TCC: black
bar; n = 3/group). Data represent mean ± SEM of each group. ANCOVA at each individual time point was
conducted using alpha diversity of dams at GD 18 as the covariate for phylogenetic diversity and Shannon’s
index followed by Bonferroni post hoc test. Statistical significance was set at p = 0.05; (*) indicates statistical
significance at each time point relative to controls.

Figure 5. Beta diversity of neonates during lactation period. Pairwise weighted UniFrac distance between
TCC exposed and control neonates is shown at postnatal days (PND) 3, 6, 12 and 16 (n =  3/group). Community
level statistical significance was analyzed using Adonis, in the Vegan package50,51. Repeated measures analysis
was conducted and significant time-treatment interactions were investigated with the Vegan package. (*)
indicates statistical significance at each time point relative to controls.

the common assumption that microbiota is transferred early on from maternal sources to neonates, we sought
to understand microbial similarity between dam samples collected near birth and neonate samples collected
throughout the study period. To do so, we further compared weighted UniFrac distances of neonatal samples
during lactation in relation to dam samples at GD 18. Figure 6A demonstrates initial clustering between control
dams at GD 18 and control neonates at PND 3; neonatal diversity then reorganized, moving away from dams
at PND 6 and again clustered more closely with dams at PND 12 and PND 16. The visualization between TCC
exposed dams and exposed neonates is shown in Fig. 6B. Note that samples of exposed neonates were isolated
away from dams at all time points.
Cecum Microbiota Community Composition. Relative abundance of microbiota present in neonate samples
revealed a dominance by three phyla: Proteobacteria, Firmicutes, and Bacteroidetes regardless of collection date or
treatment status (Fig. 7A). While increases in the proportion of Bacteroidaceae are noted in microbiota collected
from control samples, Enterobacteriaceae dominated samples collected from neonates suckled by 0.1% w/wTCC
exposed dams (Fig. 7B). Significant differences at the phylum and family level across time and exposure groups
are shown in Table 3 and Table 4 respectively.

TCC Exposure on Pathology of Neonatal Gastrointestinal Tract. Grossly, TCC exposure during ges-

tation and lactation led to enlarged abdomens with mustard colored diarrhea in neonates. The formalin fixed gut
of a control and an exposed neonate at PND 12 are shown in Fig. 8A,B respectively. Compared to controls, the
gastrointestinal tracts of TCC exposed neonates were filled with gas and liquid. H&E staining of the large (cecum)
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Figure 6. Comparison of the principal coordinate analysis of weighted UniFrac distances among samples
collected from (A) control dams (gray circles, n = 4) at GD 18 and samples collected from their offspring (n =  3)
at PNDs 3 (triangle), 6 (square), 12 (cross) and 16 (star); (B): 0.1% w/w TCC exposed dams (black circles, n =  4)
at GD 18 and samples collected from their offspring (n = 3) at PNDs 3 (triangle), 6 (square), 12 (cross) and 16
(star).

Figure 7. Relative abundance of bacteria among neonates at the phylum (A) and family (B) levels by collection
date at PNDs 3, 6, 12 and 16 (n = 3/group). At the family level, only the top 50 OTUs are shown. Taxon labels
within square brackets indicate GreenGenes proposed taxonomy.
and small intestine (jejunum) is shown between control (Fig. 8C) and TCC exposed neonates (Fig. 8D) at PND
12. No apparent histological differences were noted between the two groups.
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Least Squares Means**

Phylum*

Stain

BacteroidetesAB

Gram −
Gram +

FirmicutesA

Gram −

Proteobacteria

B

Group

PND 3

PND 6

PND 12

PND 16

Control

22.6

<1

50.3

64.8

Exposed

9.0

<1

9.4

21.3

Control

41.0

11.9

7.2

25.2
<1

Exposed

37.7

5.8

2.4

Control

35.3

87.3

34.0

7.5

Exposed

52.7

94.0

88.2

78.0

Table 3. Effect of TCC on Relative Abundance of Neonate Gut Microbial Phyla. A = Effect of time, p <  0.05;
B = Effect of treatment, p <  0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise ≥ 1% of
the relative abundance. **Least squares means displayed as percentage; PND =  postnatal day.

Least Squares Means**

Family*

Stain

BacteroidaceaeABC
Enterobacteriaceae

Gram −
B

PasteurellaceaeABC
S24−7ABC

Gram −
Gram −
Uncultured

Group

PND 3

PND 6

PND 12

PND 16

Control

12.8

<1

48.4

39.6

Exposed

7.5

<1

1.0

18.1

Control

33.3

82.1

32.4

7.2

Exposed

51.3

93.7

88.0

77.9
<1

Control

<1

5.2

1.5

Exposed

<1

<1

<1

<1

Control

6.9

<1

1.9

16.5

Exposed

<1

<1

<1

<1

Table 4. Effect of TCC on Relative Abundance of Neonate Gut Microbial Families. A = Effect of time,
p <  0.05; B = Effect of treatment, p <  0.05; C = Time-treatment interaction, p < 0.05; *Data displayed comprise
≥1% of the relative abundance. **Least squares means displayed as percentage; PND =  postnatal day.

Figure 8. Representative histology of formalin fixed gross gastrointestinal morphology in control (A) and
0.1% w/w TCC (B) exposed male neonates at PND 12. Large intestine (cecum) and small intestine (jejunum) is
shown from control (C) and 0.1% w/w TCC (D) exposed neonates at PND 12 (H&E, 20X).
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Discussion

It is common to choose non-prescription antimicrobial containing products for prophylactic reasons11,12.
TCC has been detected in human serum and cord blood suggesting a systemic distribution of this hydrophobic compound through maternal circulation16,17. Hydrophobic drugs are likely to concentrate in breast
milk because of the high lipid load22. Detection of TCC is reported in human milk, implying that as the natural and optimal food for infants, breast milk may serve as the primary exposure route to TCC among breastfed infants23. We recently demonstrated that TCC was transferred through the milk to suckling neonates21.
Pups exposed to TCC through lactation had distended gastrointestinal tracts with liquid, mustard-colored
diarrhea. Further, the concentration of TCC identified in the milk of exposed dams was four times higher
than the corresponding levels found in maternal circulation21. The potential TCC exposure among nursing infants dictates the need to investigate the effect of TCC on the gut microbiota composition during
early life.
In this study, to understand the development of gut microbial community structure in neonatal rats and
understand the dynamics of pregnant/lactating rats in response to TCC exposure, fecal/cecum material were
collected at specific time-points during gestation and lactation. Provision of TCC during gestation and lactation
altered the community structure of dam fecal microbiota over time. In dams, alpha diversity was significantly
reduced in exposed animals at all collection dates after baseline (Fig. 1A,B). Beta diversity was significantly dissimilar on both GD 18 during gestation and 16 days post-delivery (AD 16) in exposed compared to control dams
(Fig. 2, Supplementary Fig. S1). Weighted UniFrac Adonis stratified to each sample over time revealed a significant interaction between time and treatment that occurred at GD 11. Here, distances remain relatively stable
among exposed dams across the study while microbial distance among control animals becomes more dynamic
after GD 11 (Supplementary Fig. S1). Thus, it appears that TCC as an antimicrobial confines distance of exposed
dams relative to controls.
In the dam, the effect of TCC exposure on beta and alpha diversity was mirrored in the microbial relative
abundance at the phylum and family level (Fig. 3A,B). As shown in Table 1 and Table 2, the majority of microbiota that increased in relative abundance following exposure to 0.1% w/w TCC, stain Gram-negative. In addition,
Clostridiaceae, Lactobacillaceae and Turicibacteraceae that stain Gram-positive, made up a significantly increased
proportion of the relative abundance in control samples compared to TCC exposed samples. This is not altogether
surprising given that TCC shows primary efficacy for Gram-positive bacteria24. This selectivity could allow for the
overgrowth of potentially pathogenic Gram-negative strains. Though overt signs of infection were not observed
in the dam. Because we did not observe adverse gastrointestinal reactions (i.e. diarrhea) in the adult animals
during the study period, histological assessment was not conducted.
During early life, one view of antibiotic-induced dysbiosis purports that the gut microbiome responds to
prescription antibiotics with the loss of keystone taxa and metabolic shifts in the short-term5. Even after antibiotic treatment ends, keystone taxa may not have recovered and the loss of diversity could allow for the bloom of
pathogens and pathobionts. In this study, unexposed neonatal communities became more diverse over time while
TCC exposure, like prescription antibiotics5, restricted diversity of colonizing species during the same period
(Fig. 4A,B). The health outcomes of this taxa loss remain to be determined.
Among suckling neonates, TCC exposure led to microbial diversity loss. Within cecum samples collected
from exposed neonates, visually the overall alpha diversity declined overtime with significant suppression of
phylogenetic diversity at PND 16 (Fig. 4B) compared to controls. A similar pattern developed when neonatal beta
diversity was evaluated, whereby in control and TCC exposed neonates, an initial stochastic pattern emerged at
PND 3. At PND 6, an overall restructuring occurred where control and TCC exposed communities converged.
Starting from PND 12, communities separated based on exposure status and became significantly different at
PND 16 (Fig. 5, Supplementary Fig. S2). The overall restructuring that occurred among samples collected from
control neonates at PND 6 was interesting, though may provide an indication of the normal colonization process.
Using Friend leukemia virus B mice, Pantoja-Feliciano et al. demonstrated suppressed diversity at PND 3 and 9,
compared to day 1, that increased again to levels similar to dams at PND 2125. Additionally, Palmer et al. reported
that the mean Pearson’s correlation between human infant and adult fecal microbiota increased from day 0 until
around day 5 post-birth, when an apparent population rearrangement occurred resulting in the divergence from
adult samples7. Thereafter, infant microbial profiles again correlated more closely to adults throughout the first
18 months of life.
We demonstrated that distances of samples from control neonates at PND 3 clustered around microbiota of
control dams at GD 18 (Fig. 6A). By PND 6, a population shift occurred, with movement of neonates away from
that of dams. At PNDs 12 and 16, the neonatal distance from dams decreased at each respective time-point.
Microbiota may initially be acquired and only those microbes that can occupy the niche specific to the infant gut
will colonize5. We postulate that among control neonates, the initial dam-neonate similarity reflects the microbiota transferred either from the dam or environment over the first few days of life. At PND 6, only those microbes
that can occupy the neonatal cecum biome propagate. This in turn produces a more hospitable microbial environment, driving increased diversity and similarity to adult dam samples at PNDs 12 and PND 16.
The distance similarity noted between control dams at GD 18 and neonates at PND 3 was not demonstrated
among TCC exposed dams and their neonates (Fig. 6B). Here, among exposed neonates, early life TCC exposure
constrained the progression to a more diverse state. One limitation of this study design was that samples were
not collected prior to PND 3. Thus we cannot comment on the potential similarity of TCC exposed neonatal
microbiota to dams at the time of delivery. Furthermore, because exposure during gestation and lactation was
not separated, we could not dissect the effect of early microbial restriction at gestation or lactation individually.
Previously, we demonstrated that TCC could cross the placental barrier and was detected in the amniotic fluid21.
Further, research now indicates that microbial establishment may occur prenatally26. Thus, we could not rule out
the possibility that restriction demonstrated in TCC exposed neonates was an outcome of gestational exposure.
Scientific Reports | 6:33430 | DOI: 10.1038/srep33430
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Cesarean-section or a cross-fostering design could be utilized in the future to separate the effect of TCC exposure between gestation and lactation. Further, sample collection at the time of parturition would provide further
insight into the normal colonization process at early life stages.
Additional limitations such as the small sample size (n = 4 dams, and n = 3 neonates) and the fact that the neonatal samples were pooled is noted. Pooling samples reduces variability, but could also reduce the overall sample
number and statistical power. However, because TCC was administered through the chow to dams and neonatal
exposure occurred through the milk to the whole litter, statistical analysis based on the whole litter instead of
using individual neonates within each litter has been proposed27. Specifically, it might not be an ideal situation to
collect two sibling neonates from a single litter and consider these two animals as separate experimental units. In
this study, we pooled neonates collected from separate cages within each treatment group in order to reduce the
variability that might be demonstrated if only a single neonate were collected at each time point. Future investigation with increased dam numbers producing larger neonatal sample size would strengthen the power of these
studies.
The infant gut is first colonized by facultative anaerobes such as Enterobacteriaceae that lower the redox potential allowing for growth of strictly anaerobic bacteria28. Among neonates at PND 3, Enterobacteriaceae dominated in both control and treated groups (Fig. 7B, Table 4). After PND 6, Bacteroidaceae gained a stronghold in
control samples becoming significantly enhanced compared to exposed samples overtime (Table 4). In contrast,
Enterobacteriaceae maintained dominance in TCC exposed samples from PND 6 until the end of the study period
and repeated measures analysis revealed a significant effect of treatment group compared to control samples
(Table 4). The relative contribution of Enterobacteriaceae may explain the convergence at PND 6. Because TCC
shows selective efficacy for Gram-positive bacterial strains24, if mostly Gram-negative bacteria dominated at PND
6 in both groups, the effect of TCC may be minimal. However, with consistent exposure few Gram-positive bacteria, for example, may colonize overtime contributing to the diversity difference between the two groups.
Currently the specific cause of diarrhea in exposed animals is elusive. It is possible that exposure to TCC
allowed for colonization of pathogenic members of the Enterobacteriaceae family and subsequent infection.
Because samples were pooled, if only certain neonates of a pool were colonized by a pathogenic strain of E.coli, for
example, the total contribution might be minimized and infection based solely on microbial abundance may be
overlooked. However, all TCC exposed neonates displayed distended abdomens (Fig. 8B) and diarrhea, indicating
that if infection/diarrhea was the result of an overgrowth of a certain member of the Enterobacteriaceae family,
pooling samples would not mask the effect. Enterobacteriaceae bloom in the gut microbiota is documented among
human infants in response to prescription antibiotics and is associated with potentially life threatening diseases
such as necrotizing enterocolitis29–31. Furthermore, a reduction in the ratio of Bacteriodeace to Enterobacteriaceae
of the human infant gut is indicated in later-life health outcomes, such as food sensitivities32. Collectively, our
results should drive future research regarding both short and long-term health consequences related to TCC
exposure in humans, specifically during early life.
It was interesting to note that exposed neonates showed distended abdomens (Fig. 8B) with mustard-colored
diarrhea, though no apparent histopathological differences were identified (Fig. 8C,D). Currently, the mechanism
of TCC-induced diarrhea among the neonates is unknown. However, given its antimicrobial nature, TCC may act
similarly to prescription antibiotics. The use of many prescription drugs, including antibiotics, can lead to diarrhea onset, commonly without organic lesions33. Antibiotic-associated diarrhea (AAD) is unexplained diarrhea
that is associated with antibiotic administration34. The mechanisms of AAD are diverse and may be related to the
pharmacokinetic properties of the drug itself or to suppression of the gut microbiota. Future investigation may
benefit from the use of gnobiotic animals to rule out the interaction of TCC on the gut microbiota to determine
whether diarrhea was a primary effect of TCC exposure or secondary to its action on the gut microbiota.

Conclusion

Oscillations in the gut microbial community structure can occur with exposure to prescription antibiotics leading to dysbiosis of the gut ecosystem35. These compositional changes can induce opportunistic pathogen overgrowth resulting in infectious disease (i.e. C. difficile infection) in the short-term and chronic disease (i.e. asthma)
throughout life. Like prescription antibiotics, we demonstrated the ability of a non-prescription antimicrobial
TCC, to induced gut microbial dysbiosis during sensitive exposure windows in a rat model. Collectively, our
results add to the growing public concern related to the potential human health impact of non-prescription antimicrobial exposure and should guide regulatory agencies in policy decisions regarding the use of non-prescription
antimicrobials in personal care products during critical physiological stages.

Materials and Methods

Animals and Husbandry. Timed-pregnant Sprague Dawley (SD) rats were purchased from Harlan
Laboratory (Dublin, VA). The day after mating was designated as gestational day (GD) 1. Upon arrival, animals were weight ranked and randomly assigned to control or treatment groups (n = 4/group). Animals were
housed individually under specified conditions (12:12-hour light cycle, temperature of 20 °C to 22 °C, and relative
humidity of 40% to 50%) with ad libitum access to water and commercial Harlan ground 2020X chow or 2020X
supplemented with 0.1% w/w TCC (purity 99%, Sigma Aldrich, St Louis, Missouri) daily from GD 4 until 16
days after delivery. This period was chosen as we demonstrated that TCC could cross the placental barrier and
accumulate in the milk of lactating rats21. We previously demonstrated that the serum TCC concentration of
pregnant rats after oral exposure to 0.2% w/w TCC was similar to or within an order of magnitude of the concentrations reported in the blood of human volunteers, specifically in those who were regular users of TCC containing soap21,36. Parturition occurred naturally. The Animal Use and Care Committee at the University of Tennessee,
Knoxville, approved all study protocols. All methods were conducted in accordance with the Institutional Animal
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Care and Use Committee (IACUC) guidelines. This investigation was conducted in an animal facility fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care.

Fecal/cecum Sample Collection. Fecal samples from dams (n = 4/group) and cecum content (n =  3/
group) from neonates were collected at designated dates throughout gestation and lactation. Briefly, for fecal collection, an individual dam was removed from the home cage and placed in a clean cage free of bedding. The tail of
the rat was lifted to facilitate the discharge of feces. Stainless steel forceps were used to collect fecal pellets immediately after the samples were produced. All tools were autoclaved prior to use and changed between cages. Fecal
samples were collected at baseline (GD 4), 7 days post-treatment (GD 11), 14 days post-treatment (GD 18), and
16 days after delivery (AD) corresponding to 34 days after the initiation of exposure regimen. No fecal samples
were collected from dams between GD 18 and any days prior to the final day of the study to reduce disturbance
prior to the delivery and during lactation.
Collection of cecum content from neonates was a terminal procedure. Samples were collected between 8:00
AM and 12:00 PM on the day of sacrifice. At postnatal day (PNDs) 3, 6, 12 and 16, within each group, two female
neonates were randomly selected from each dam. Cecum content from each neonate was removed and combined
into three pools so that no individual pool contained two neonates born to the same dam. The maternal origin of
the composition of each pool was made consistent at each subsequent collection date. In other words, if cecum
content from a neonate born to a specific dam was added to a designated pool on PND 3, cecum content from an
additional neonate born to the same dam was used to create the same pool on PND 6. Fecal/cecum samples were
snap frozen immediately following collection and stored at −80 ° C until analysis.
Neonatal Histology. At PND 12, neonatal gastrointestinal tracts (jejunum and cecum) were collected from
male neonates with or without TCC exposure during lactation and fixed in 10% formalin. Tissue sections were
examined with hematoxylin-eosin (H&E) staining. A board-certified pathologist, blinded to treatment status,
evaluated histological changes.
DNA Isolation, Amplification, and 16S rRNA Sequencing.

DNA Extraction, Amplification and
Clean-up. DNA was extracted from frozen fecal/cecum samples with the Power fecal DNA isolation kit (Mo Bio
Laboratories, Inc. Carlsbad, CA) following manufacturer’s instructions. Extracted DNA samples were quantified
with Nanodrop 1000 and stored at −80 °C until PCR amplification. DNA was amplified by targeting the V4
region of the bacterial 16S rRNA gene as described by Caporaso et al.37.
The initial PCR product was purified with DNA gel electrophoresis to remove DNA impurities and primer
dimers. The concentration of purified amplicon product was measured with Qubit dsDNA HS Assay Kit (Life
Technologies, Carlsbad, CA) and normalized to an equal concentration to create a single amplicon pool.

™

Bacterial Barcoded Amplicon Library Preparation, Sequencing and Sequence Analysis. Beads

Clean-up. Pooled amplicons were purified with SPRIselect (Beckman Coulter, Inc., Indianapolis, IN) following
the manufacturer’s protocol (Next-flex 16S V4 Amplicon Seq-kit manual). The products were analyzed with
Agilent High Sensitivity DNA Analysis (CHIP) Kit for quality assurance on a 2100 Bioanalyzer (Agilent, Santa
Clara, CA).

™

Library Quantification and Illumina Sequencing. The pooled amplicon library concentration was quantified
with the Illumina Library Quantification kit (KAPA Biosystems, Boston, MA) prior to sequencing. Quantitative
PCR was performed with the KAPA SYBR FAST qPCR Master Mix (2X). The amplicon library was diluted to
a starting concentration of 10 nM and sequenced on the Illumina MiSeq sequencer (Illumina, Inc., San Diego, CA).

®

Sequence Data Analysis. The resulting raw sequencing data was analyzed using the QIIME (v1.8.0) pipeline38.
Unless otherwise stated all python scripts reside within QIIME. The script, join_paired_ends.py, was used to
generate the assembled paired-end reads. Next, paired-end sequences were demultiplexed and quality filtered
with Phred score no less than 20. The UCHIME program was used to detect chimeras on assembled reads via
identify_chimeric_seqs.py39. Operational taxonomic units (OTU) were generated using the script, pick_open_
reference_otus.py, with 97% similarity via USEARCH40,41. The OTU taxonomy was assigned using the Ribosomal
Database Project (RDP) classifier42 with the May 2013 Greengenes release in QIIME43,44, and then aligned via
PyNAST45. Any OTU present at less than 0.005% of the total read count was filtered to remove the potential
influence of spurious OTUs46,47. The resulting filtered output was used to make a phylogeny (make_phylogeny.
py). The phylogeny was then rooted to Bacteroidetes. All samples were rarefied at a minimum sequencing depth
of 55,000 OTUs. The script alpha_rarefaction.py was used to confirm the appropriate minimum sequencing depth
across samples. 16S datasets were deposited in the Sequence Read Archive under accession number: SRP067613.

Statistics.

Statistical analysis was conducted in R (version 3.1.2) using Phyloseq unless otherwise noted48.
Microbial community composition by treatment group at each fecal/cecum collection date was visualized using
Principal Coordinate Analysis (PcoA) and boxplots constructed with weighted UniFrac distances49. Community
level statistical significance was tested with the nonparametric Adonis function in the Vegan package at each
individual time-point50,51. Adonis permutations were stratified by collection date among neonates in the Vegan
package to account for sampling across time. A repeated measures permanova was conducted on dam samples
stratified by rat ID using the BiodiversityR package, with separate whole and sub-plot analyses52. Post-hoc analysis
of repeated measures Adonis results were analyzed with the Vegan package to dissect significant time-treatment
interactions. Within sample richness and evenness were estimated using Shannon’s index. Faith’s phylodiversity
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(PD) metric was calculated via QIIME53. Dam alpha diversity estimates were analyzed using two-way ANOVA
with repeated measures and neonate alpha diversity was analyze by ANCOVA using dam GD 18 alpha diversity as
a covariate in SigmaPlot (version 13) with Bonferroni post-hoc test. Data were presented as group mean ±  SEM.
Relative abundance of OTUs at the phyla and family level were visualized with Phyloseq48. Statistical significance
was set at alpha = 0.05. Relative abundance was analyzed statistically using the glm function in R. Time and treatment fixed effects were analyzed with ANOVA and Fisher’s LSD mean separation (lsmeans package)54.
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